We are live on
!
Find out more
Schroder Investment Management Group Portfolio holdings
AUM
$122B
1-Year Est. Return
29.27%
This Fund
S&P 500
This Quarter
Est. Return
+4.43%
1 Year Est. Return
+29.27%
3 Year Est. Return
+98.87%
5 Year Est. Return
+131.84%
10 Year Est. Return
+513.68%
AUM
$55.5B
AUM Growth
-$172M
(-0.31%)
Cap. Flow
-$1.67B
Cap. Flow
% of AUM
-3.01%
Top 10 Holdings %
Top 10 Hldgs %
17.35%
Holding
1,386
New
149
Increased
531
Reduced
497
Closed
109
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$180M |
| 2 |
J.M. Smucker
SJM
|
+$145M |
| 3 |
Labcorp
LH
|
+$114M |
| 4 |
Bank of America
BAC
|
+$102M |
| 5 |
Verizon
VZ
|
+$86M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.12B |
| 2 |
Itaú Unibanco
ITUB
|
+$278M |
| 3 |
Quest Diagnostics
DGX
|
+$170M |
| 4 |
Walmart Inc
WMT
|
+$131M |
| 5 |
PepsiCo
PEP
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.1% |
| 2 | Financials | 16.59% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Healthcare | 12.04% |
| 5 | Industrials | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Neurocrine Biosciences
NBIX
$16.6B
| $948K | ﹤0.01% |
20,496
| – | – |
|
|
BID
977
DELISTED
Sotheby's
BID
| $936K | ﹤0.01% |
+17,600
| New | +$877K |
|
|
TCO
978
DELISTED
Taubman Centers Inc.
TCO
| $934K | ﹤0.01% |
15,525
-773
| -5% | -$47.7K |
|
979
Illumina
ILMN
$28.4B
| $933K | ﹤0.01% |
5,428
| – | – |
|
980
Forestar Group
FOR
$1.51B
| $930K | ﹤0.01% |
+54,245
| New | +$809K |
|
981
Sturm, Ruger & Co
RGR
$593M
| $929K | ﹤0.01% |
13,786
-6,577
| -32% | -$409K |
|
982
Chemours
CC
$2.37B
| $927K | ﹤0.01% |
26,100
+22,000
| +537% | +$868K |
|
|
NTRI
983
DELISTED
NutriSystem, Inc.
NTRI
| $927K | ﹤0.01% |
17,690
-14,915
| -46% | -$772K |
|
984
American Tower
AMT
$80.4B
| $926K | ﹤0.01% |
6,978
+2,597
| +59% | +$333K |
|
985
IQVIA
IQV
$39.3B
| $926K | ﹤0.01% |
10,355
-40,214
| -80% | -$3.4M |
|
|
GTY
986
Getty Realty Corp
GTY
$2.07B
| $921K | ﹤0.01% |
36,700
+1,400
| +4% | +$35.9K |
|
987
Rayonier Advanced Materials
RYAM
$610M
| $919K | ﹤0.01% |
58,284
-223,000
| -79% | -$3.18M |
|
|
DST
988
DELISTED
DST Systems Inc.
DST
| $916K | ﹤0.01% |
15,106
-155,716
| -91% | -$9.5M |
|
989
Patterson-UTI
PTEN
$3.76B
| $914K | ﹤0.01% |
45,409
-10,898
| -19% | -$237K |
|
990
Cintas
CTAS
$81.3B
| $908K | ﹤0.01% |
+29,204
| New | +$909K |
|
|
TWX
991
DELISTED
Time Warner Inc
TWX
| $902K | ﹤0.01% |
9,048
+8,232
| +1,009% | +$815K |
|
992
Bloomin' Brands
BLMN
$937M
| $897K | ﹤0.01% |
+42,288
| New | +$872K |
|
|
MZTI
993
The Marzetti Company
MZTI
$3.11B
| $896K | ﹤0.01% |
7,371
-2,115
| -22% | -$265K |
|
994
Southwest Gas
SWX
$6.67B
| $890K | ﹤0.01% |
12,220
-6,594
| -35% | -$527K |
|
|
MNK
995
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $888K | ﹤0.01% |
20,000
+16,500
| +471% | +$724K |
|
996
Smith & Wesson
SWBI
$637M
| $881K | ﹤0.01% |
+47,861
| New | +$825K |
|
997
Avista
AVA
$3.24B
| $876K | ﹤0.01% |
+20,600
| New | +$860K |
|
998
Sabra Healthcare REIT
SBRA
$5.37B
| $876K | ﹤0.01% |
36,807
-1,841
| -5% | -$46.8K |
|
|
IPHS
999
DELISTED
Innophos Holdings, Inc.
IPHS
| $867K | ﹤0.01% |
19,858
+14,598
| +278% | +$655K |
|
1000
Insperity
NSP
$2.01B
| $859K | ﹤0.01% |
24,034
-16,028
| -40% | -$649K |
|
Similar funds
VAM
Schroder Investment Management Group's Q2 2017 Portfolio in Review
As of Q2 2017, Schroder Investment Management Group held 1,386 positions worth $55.5B, down 0.31% from $55.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Schroder Investment Management Group withdrew a net $1.67B in Q2 2017, closing 109 positions and reducing 497 holdings. Its most notable exit was PrivateBancorp Inc, an estimated $89.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Schroder Investment Management Group opened a new position in Stericycle Inc worth $80.5M.
- Schroder Investment Management Group's largest Q2 2017 buy was Stericycle Inc: 1,042,443 shares worth $80.5M.
- Schroder Investment Management Group added most to Johnson & Johnson in Q2 2017, an estimated $180M increase.
- Schroder Investment Management Group's biggest Q2 2017 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.12B.
- Schroder Investment Management Group fully exited PrivateBancorp Inc in Q2 2017, selling an estimated $89.4M.
- Schroder Investment Management Group's ten largest holdings make up 17% of its $55.5B portfolio in Q2 2017.
- Schroder Investment Management Group opened 149 new positions and closed 109 in Q2 2017.
- Schroder Investment Management Group's portfolio value fell 0.31% quarter-over-quarter to $55.5B.
Based on Schroder Investment Management Group's 13F filing for Q2 2017, filed 10 Aug 2017.